Publications by authors named "Caelan Taggart"

Claim this Profile
C
Cardiovascular and non-cardiovascular mortality at 5 years in patients with type 1 and type 2 myocardial infarction.
Caelan Taggart, Alexander J F Thurston, Deepak Harry, Yong Yong Tew, Ryan Wereski

Eur Heart J Acute Cardiovasc Care· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The assessment and management of patients with type 2 myocardial infarction: an international Delphi study.
Caelan Taggart, Amy V Ferry, Andrew R Chapman, Stacey D Schulberg, Anda Bularga

Eur Heart J Qual Care Clin Outcomes· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Decisions and Outcomes After Switching High-Sensitivity Cardiac Troponin Assays in Suspected ACS: An Interrupted Time-Series Study.
Jasper Boeddinghaus, Ziwen Li, Anda Bularga, Caelan Taggart, Ryan Wereski

JAMA Cardiol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of Using Risk Stratification Along With High-Sensitivity Cardiac Troponin in the Emergency Department: A Secondary Analysis.
Ziwen Li, Dimitrios Doudesis, Anda Bularga, Ryan Wereski, Caelan Taggart

J Am Coll Cardiol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Investigation and Treatment in Type 2 Myocardial Infarction: A Pilot Randomized Controlled Trial.
Caelan Taggart, Amy Ferry, Stephanie Barker, Kelly Williams, Grace Souter

JACC Adv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implications of a new clinical classification of acute myocardial infarction.
Jasper Boeddinghaus, Anda Bularga, Caelan Taggart, Ryan Wereski, Michael McDermott

Eur Heart J Acute Cardiovasc Care· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type 2 myocardial infarction: challenges in diagnosis and treatment.
Andrew R Chapman, Caelan Taggart, Jasper Boeddinghaus, Nicholas L Mills, Keith A A Fox

Eur Heart J· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantification of carotid artery plaque and peri-vascular adipose tissue attenuation on computed tomography.
Beth Whittington, Viswan Thiagarajah, Evangelos Tzolos, Jakub Kaczynski, Caelan Taggart

Eur Heart J Imaging Methods Pract· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical decision aids and computed tomography coronary angiography in patients with suspected acute coronary syndrome.
Kang-Ling Wang, Caelan Taggart, Michael McDermott, Rachel O'Brien, Katherine Oatey

Emerg Med J· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The electronic frailty index and outcomes in patients with myocardial infarction.
Matthew T H Lowry, Dorien M Kimenai, Dimitrios Doudesis, Konstantin Georgiev, Michael McDermott, Caelan Taggart

Age Ageing· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of the Universal Definition of Myocardial Infarction in Clinical Practice in Scotland and Sweden.
Caelan Taggart, Andreas Roos, Erik Kadesjö, Atul Anand, Ziwen Li

JAMA Netw Open· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of a high sensitivity cardiac troponin I assay and risk of myocardial infarction or death at five years: observational analysis of a stepped wedge, cluster randomised controlled trial.
Kuan Ken Lee, Dimitrios Doudesis, Amy V Ferry, Andrew R Chapman, Dorien M Kimenai, Caelan Taggart

BMJ· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Troponin in early presenters to rule out myocardial infarction.
Matthew T H Lowry, Dimitrios Doudesis, Jasper Boeddinghaus, Dorien M Kimenai, Anda Bularga, Caelan Taggart

Eur Heart J· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Sensitivity Cardiac Troponin for Risk Assessment in Patients With Chronic Coronary Artery Disease.
Ryan Wereski, Philip Adamson, Nur Shazlin Shek Daud, Michael McDermott, Caelan Taggart

J Am Coll Cardiol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Troponin in acute chest pain to risk stratify and guide effective use of computed tomography coronary angiography (TARGET-CTCA): a randomised controlled trial.
Kuan Ken Lee, David Lowe, Rachel O'Brien, Ryan Wereski, Anda Bularga, Caelan Taggart

Trials· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving Risk Stratification for Patients With Type 2 Myocardial Infarction.
Caelan Taggart, Karla Monterrubio-Gómez, Andreas Roos, Jasper Boeddinghaus, Dorien M Kimenai

J Am Coll Cardiol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Historical cardiac troponin concentrations in patients with suspected acute coronary syndrome.
Caelan Taggart, Andrew R Chapman

Heart· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of Age on the Diagnosis of Myocardial Infarction.
Matthew T H Lowry, Dimitrios Doudesis, Ryan Wereski, Dorien M Kimenai, Christopher Tuck, Caelan Taggart

Circulation· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinguishing Type 1 from Type 2 Myocardial Infarction by Using CT Coronary Angiography.
Mohammed N Meah, Anda Bularga, Evangelos Tzolos, Andrew R Chapman, Marwa Daghem, Caelan Taggart

Radiol Cardiothorac Imaging· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Oxygen Supply-Demand Imbalance and Outcomes Among Patients With Type 2 Myocardial Infarction: A Secondary Analysis of the High-STEACS Cluster Randomized Clinical Trial.
Anda Bularga, Caelan Taggart, Filip Mendusic, Dorien M Kimenai, Ryan Wereski

JAMA Netw Open· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coronary Artery and Cardiac Disease in Patients With Type 2 Myocardial Infarction: A Prospective Cohort Study.
Anda Bularga, John Hung, Marwa Daghem, Stacey Stewart, Caelan Taggart

Circulation· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for type 1 and type 2 myocardial infarction.
Ryan Wereski, Dorien M Kimenai, Anda Bularga, Caelan Taggart, David J Lowe

Eur Heart J· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac Troponin Thresholds and Kinetics to Differentiate Myocardial Injury and Myocardial Infarction.
Ryan Wereski, Dorien M Kimenai, Caelan Taggart, Dimitrios Doudesis, Kuan Ken Lee

Circulation· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis, Investigation and Management of Patients with Acute and Chronic Myocardial Injury.
Caelan Taggart, Ryan Wereski, Nicholas L Mills, Andrew R Chapman

J Clin Med· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis